Shao Mu Guo
Directeur/Membre du Conseil chez YIDA CHINA HOLDINGS LIMITED
Postes actifs de Shao Mu Guo
Sociétés | Poste | Début | Fin |
---|---|---|---|
YIDA CHINA HOLDINGS LIMITED | Directeur/Membre du Conseil | 01/06/2014 | - |
Independent Dir/Board Member | 01/06/2014 | - | |
GALAXYCORE INC. | Directeur/Membre du Conseil | 23/01/2014 | - |
Independent Dir/Board Member | 23/01/2014 | - | |
FANTASIA HOLDINGS GROUP CO., LIMITED | Directeur/Membre du Conseil | 01/02/2015 | - |
Independent Dir/Board Member | 01/02/2015 | - | |
SUNKWAN PROPERTIES GROUP LIMITED | Directeur/Membre du Conseil | 27/10/2020 | - |
Independent Dir/Board Member | 27/10/2020 | - | |
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Directeur/Membre du Conseil | 23/11/2020 | - |
Independent Dir/Board Member | 23/11/2020 | - | |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Directeur/Membre du Conseil | 01/01/2018 | - |
Independent Dir/Board Member | 01/01/2018 | - | |
Shanghai Xinwei Medical Technology Co., Ltd.
Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - |
Historique de carrière de Shao Mu Guo
Anciens postes connus de Shao Mu Guo
Sociétés | Poste | Début | Fin |
---|---|---|---|
GANGLONG CHINA PROPERTY GROUP LIMITED | Directeur/Membre du Conseil | 01/06/2020 | 01/12/2023 |
Independent Dir/Board Member | 01/06/2020 | 01/12/2023 | |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Corporate Officer/Principal | 01/04/2007 | 01/04/2013 |
░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Shao Mu Guo
Zhejiang University | Undergraduate Degree |
University of Southern California | Graduate Degree |
Yale School of Management | Masters Business Admin |
Statistiques
Internationale
Chine | 10 |
Hong Kong | 7 |
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 10 |
Independent Dir/Board Member | 8 |
Corporate Officer/Principal | 6 |
Sectorielle
Finance | 8 |
Consumer Services | 4 |
Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 6 |
---|---|
YIDA CHINA HOLDINGS LIMITED | Finance |
GALAXYCORE INC. | Electronic Technology |
FANTASIA HOLDINGS GROUP CO., LIMITED | Finance |
GANGLONG CHINA PROPERTY GROUP LIMITED | Finance |
SUNKWAN PROPERTIES GROUP LIMITED | Finance |
SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
Entreprise privées | 10 |
---|---|
Citigroup Global Markets China Ltd. | |
Salomon Smith Barney, Inc. | Finance |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
HSBC Markets Asia Ltd. | |
Morgan Stanley Asia Ltd.
Morgan Stanley Asia Ltd. Investment Banks/BrokersFinance Morgan Stanley Asia Ltd. (MSA) is a broker/dealer headquartered in Hong Kong. The firm was founded in 1987 and is a subsidiary of Morgan Stanley (NYSE: MS) in the US. MSA provides institutional securities such as equities, fixed income, derivatives and research. | Finance |
Ljmjl Advisors Hk Ltd. | |
Mjl Fun Ltd. | |
HSBC Investment Asia Holdings Ltd. | |
JPMorgan Chase Bank (China) Co. Ltd.
JPMorgan Chase Bank (China) Co. Ltd. Regional BanksFinance Part of JPMorgan Chase & Co., JPMorgan Chase Bank (China) Co. Ltd. is a Chinese company that offers trade finance, cash management, and commercial banking. The company is based in Beijing, China. | Finance |
Shanghai Xinwei Medical Technology Co., Ltd.
Shanghai Xinwei Medical Technology Co., Ltd. BiotechnologyHealth Technology Shanghai Xinwei Medical Technology Co., Ltd. develops products for the prevention and treatment of stroke. The company is based in Shanghai, China. The Chinese company was founded in 2016 by Guo Hui Wang, who has been the CEO since 2016. | Health Technology |
- Bourse
- Insiders
- Shao Mu Guo
- Expérience